BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21080072)

  • 1. Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility.
    Zenker M; Mertens PR
    Int Urol Nephrol; 2010 Dec; 42(4):1131-4. PubMed ID: 21080072
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein L1 and Kidney Disease in African Americans.
    Friedman DJ; Pollak MR
    Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics: APOL1 risk variants drive kidney disease in mice.
    Allison SJ
    Nat Rev Nephrol; 2017 May; 13(5):259. PubMed ID: 28262774
    [No Abstract]   [Full Text] [Related]  

  • 4. APOL1 Kidney Disease Risk Variants: An Evolving Landscape.
    Dummer PD; Limou S; Rosenberg AZ; Heymann J; Nelson G; Winkler CA; Kopp JB
    Semin Nephrol; 2015 May; 35(3):222-36. PubMed ID: 26215860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 6. APOL1 nephropathy: from gene to mechanisms of kidney injury.
    Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
    Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
    Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy Number Variation at the APOL1 Locus.
    Ruchi R; Genovese G; Lee J; Charoonratana VT; Bernhardy AJ; Alper SL; Kopp JB; Thadhani R; Friedman DJ; Pollak MR
    PLoS One; 2015; 10(5):e0125410. PubMed ID: 25933006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the Intracellular Function of APOL1.
    Bruggeman LA; O'Toole JF; Sedor JR
    J Am Soc Nephrol; 2017 Apr; 28(4):1008-1011. PubMed ID: 28196842
    [No Abstract]   [Full Text] [Related]  

  • 10. APOL1 Nephropathy Risk Variants Through the Life Course: A Review.
    Itoku A; Isaac J; Wilson S; Reidy K; Kaskel F
    Am J Kidney Dis; 2024 Jul; 84(1):102-110. PubMed ID: 38341125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of kidney failure and the evolving story of APOL1.
    Friedman DJ; Pollak MR
    J Clin Invest; 2011 Sep; 121(9):3367-74. PubMed ID: 21881214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
    Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
    J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Biomarking" the transition from genetic risk to kidney disease.
    Kruzel-Davila E; Skorecki K
    Kidney Int; 2018 Jun; 93(6):1270-1272. PubMed ID: 29792270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOL1 and blood pressure changes in young adults.
    Nadkarni GN; Coca SG
    Kidney Int; 2017 Oct; 92(4):793-795. PubMed ID: 28938952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction?
    Kopp JB
    Kidney Int; 2013 Dec; 84(6):1069-72. PubMed ID: 24280748
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ma L; Chou JW; Snipes JA; Bharadwaj MS; Craddock AL; Cheng D; Weckerle A; Petrovic S; Hicks PJ; Hemal AK; Hawkins GA; Miller LD; Molina AJ; Langefeld CD; Murea M; Parks JS; Freedman BI
    J Am Soc Nephrol; 2017 Apr; 28(4):1093-1105. PubMed ID: 27821631
    [No Abstract]   [Full Text] [Related]  

  • 17. APOL1 variants and kidney disease. There is no such thing as a free lunch.
    Kronenberg F
    Nephrol Dial Transplant; 2011 Mar; 26(3):775-8. PubMed ID: 21216884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 Variants: From Parasites to Kidney Function to Cardiovascular Disease.
    Reiner AP; Susztak K
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):219-20. PubMed ID: 26819463
    [No Abstract]   [Full Text] [Related]  

  • 20. APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.
    Fu Y; Zhu JY; Richman A; Zhang Y; Xie X; Das JR; Li J; Ray PE; Han Z
    J Am Soc Nephrol; 2017 Apr; 28(4):1106-1116. PubMed ID: 27864430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.